Nesta is an independent non-profit foundation based in London, United Kingdom, founded in 1998 with an endowment from the UK National Lottery. The organization is dedicated to fostering innovation, talent, and creativity to address significant societal challenges. Nesta specializes in making direct and fund of fund investments in a variety of sectors, with a strong emphasis on technology, including engineering, software, healthcare, and cleantech. It invests across different stages, from seed to growth, and prefers to take an active role by securing board seats in its portfolio companies. In addition to its investment activities, Nesta engages in research and practical programs aimed at improving lives and driving social change. The foundation collaborates with various partners to identify and develop transformative ideas that can make a meaningful impact.
Executive Director of Investments, Impact Investments
Emily Bushby
Deputy CEO
Leo Chandler
Investment Manager
Lucy Heady
Impact Director
Alex Hook
Senior Investment Director
John Loder
Investment Director - Health Sector, Impact Investments
104 past transactions
Mixergy
Venture Round in 2025
Mixergy Ltd, founded in 2014 and based in Cassington, United Kingdom, specializes in the development of energy storage equipment, particularly hot water tanks. The company aims to provide cost-effective solutions that enhance energy efficiency and support the integration of renewable energy sources. By optimizing the use of solar photovoltaic systems and heat pumps, Mixergy tanks contribute to grid balancing, promoting greater utilization of renewable power generation.
Descycle
Series A in 2024
Descycle is a British startup specializing in e-waste recycling and metal recovery. The company has developed innovative metal recycling technology that eliminates the need for toxic chemicals, offering a more environmentally friendly alternative to conventional recycling methods. By focusing on the recovery of valuable metals from electronic waste, Descycle aims to provide significant environmental and economic benefits, allowing industries to reduce their carbon footprint. This approach enables businesses to recycle metals efficiently while maintaining a commitment to sustainability and promoting a cleaner environment. Descycle's disruptive technology positions it as a leader in the e-waste recycling sector.
Anaphite
Series A in 2024
Anaphite Limited, established in 2016 and located in Bristol, United Kingdom, focuses on the development of graphene-based nanomaterials. The company specializes in creating graphene-enhanced cathodes designed for high-power, high-energy, and cost-effective lithium-ion batteries. Anaphite's innovative approach involves integrating graphene into composite materials through a scalable and economical process. This technology results in advanced properties that make their nanomaterials suitable for a variety of applications, including energy storage, air purification, and thermal management. By prioritizing affordability and versatility, Anaphite aims to make significant contributions to the commercialization of these technologies.
Nandi Proteins
Convertible Note in 2024
Nandi Proteins Limited is a technology-driven company based in Edinburgh, United Kingdom, focused on enhancing the functional properties of proteins in food manufacturing and nutrition. Established in 2000 and spun out of Heriot Watt University in 2001, the company specializes in patented processes that improve common proteins such as whey, egg, and soy. Nandi Proteins aims to be a leader in denatured protein technology, facilitating growth through direct trading of value-added proteins and strategic licensing agreements with industry partners. Its innovative approach employs a combination of heat, time, and temperature control to modify proteins, enabling food and beverage manufacturers to achieve desirable characteristics and health benefits while efficiently extracting valuable components like enzymes.
Electron
Venture Round in 2023
Electron is a London-based energy technology company focused on decarbonizing energy systems through innovative, user-driven market interactions. The company provides a market platform as a service, allowing network operators and distributed energy resources to trade and optimize the use of network capacity alongside zero carbon, zero marginal cost power. Its infrastructure leverages blockchain technology to create efficient and resilient energy systems, addressing challenges in the sector while maximizing the potential of distributed renewable generation, storage capacity, smart grids, and connected devices. By facilitating granular and optimized marketplaces, Electron aims to transform the energy landscape and support the transition to sustainable energy solutions.
Martee’s
Pre Seed Round in 2023
Martee’s revolutionizing workplace nutrition with a fully managed, self-serve healthy meals and snacks solution.
Mixergy
Venture Round in 2023
Mixergy Ltd, founded in 2014 and based in Cassington, United Kingdom, specializes in the development of energy storage equipment, particularly hot water tanks. The company aims to provide cost-effective solutions that enhance energy efficiency and support the integration of renewable energy sources. By optimizing the use of solar photovoltaic systems and heat pumps, Mixergy tanks contribute to grid balancing, promoting greater utilization of renewable power generation.
Econest
Pre Seed Round in 2023
Econest sources and purchases energy inefficient properties to retrofit and manage at scale for large investment portfolios.
Airex
Series A in 2022
Airex Technologies, founded in 2016 and based in London, specializes in smart ventilation control solutions. The company designs intelligent air ventilation units that utilize atmospheric sensors and cloud algorithms to optimize airflow through air-bricks. Its retrofit system enables homeowners to achieve reduced energy bills, improved thermal comfort, and enhanced air quality while minimizing disturbances. By employing advanced algorithms, Airex's technology automatically regulates airflow based on local weather and air quality data, ensuring a healthier indoor environment.
Naked Energy
Series B in 2022
Naked Energy Ltd., founded in 2009 and based in Crawley, United Kingdom, specializes in the manufacture of innovative hybrid solar technology that generates both electricity and heat for various applications. The company's flagship product, Virtu®, utilizes a modular design that incorporates crystalline photovoltaic cells within an evacuated solar thermal collector. This approach allows for the conversion of a significant portion of solar energy—up to 80% of the available 1000W/m2—into usable heat and electricity, regardless of geographic or climatic conditions. The technology is particularly advantageous in urban settings with limited space, making it suitable for a range of customers, including hotels, hospitals, and manufacturing facilities. Naked Energy is in the final stages of preparing for the commercial launch of this scalable and disruptive solution, which aims to enhance energy efficiency and reduce consumption in both domestic and industrial markets.
Oxford Medical Products
Venture Round in 2022
Oxford Medical Products is focused on developing an innovative gastro-retentive hydrogel technology aimed at addressing weight loss challenges. The company has created a self-expanding capsule that occupies space in the stomach, effectively reducing hunger and promoting significant weight loss. This technology is designed to expand rapidly upon ingestion, providing a lasting feeling of satiety. Over time, the capsule breaks down gradually and passes naturally through the digestive system. Comprising a team of scientists, medical professionals, and entrepreneurs, Oxford Medical Products is dedicated to providing a safe, effective, and affordable solution to one of the world's pressing health issues.
The Behavioural Insights Team
Acquisition in 2021
The Behavioural Insights Team is an organization dedicated to applying nudge theory to enhance government policy and public services. Established as a joint venture between its employees, the UK government, and Nesta, a leading innovation charity, the team focuses on integrating insights from behavioral economics, psychology, and social anthropology. By understanding how individuals make decisions and respond to various options, the team aims to design effective policies and interventions that empower people to make better choices for themselves and society. Collaborating with governments, local authorities, businesses, and charities, the organization seeks to improve public outcomes and foster positive community impact through informed decision-making.
Would You Rather Be
Grant in 2021
Would You Rather Be is an AI-powered career planning platform that assists individuals in identifying suitable career paths aligned with their interests, skills, and qualifications. The platform employs comparative judgment techniques to enhance users' exploration of various careers, ultimately facilitating informed decision-making regarding future employment opportunities. By leveraging artificial intelligence, it aims to improve the efficiency and effectiveness of career guidance sessions, offering valuable data and analysis to users. Recently acquired by Learning Curve Group, a prominent training provider in the UK, the platform has been recognized for its innovative approach to career mapping and planning.
Would You Rather Be
Grant in 2020
Would You Rather Be is an AI-powered career planning platform that assists individuals in identifying suitable career paths aligned with their interests, skills, and qualifications. The platform employs comparative judgment techniques to enhance users' exploration of various careers, ultimately facilitating informed decision-making regarding future employment opportunities. By leveraging artificial intelligence, it aims to improve the efficiency and effectiveness of career guidance sessions, offering valuable data and analysis to users. Recently acquired by Learning Curve Group, a prominent training provider in the UK, the platform has been recognized for its innovative approach to career mapping and planning.
Find Others
Grant in 2019
Find Others is an online legal platform designed to empower individuals to unite and seek justice through collective action. It addresses the challenges victims face when pursuing accountability for various injustices, including human rights abuses and privacy violations. By providing a central hub for individuals to organize campaigns, lobby for change, or pursue legal action, Find Others simplifies the litigation process and helps balance the power dynamics between individuals and larger organizations. The platform also offers legal professionals essential tools to manage group cases effectively, facilitating collaboration from initiation to resolution. Through collective efforts, Find Others enables users to challenge entities that have historically been perceived as untouchable, reinforcing the notion that individuals can collectively assert their rights and demand change.
Symetrica
Venture Round in 2019
Symetrica Ltd. specializes in the development and commercialization of integrated radiation detection and identification technologies tailored for government and custom organizations across the globe. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, the company offers advanced systems that enhance security operations in various sectors, including military and homeland security. Its product range features handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, all utilizing machine learning to improve threat identification and response. Symetrica's technology is also applicable in fields such as medical diagnostics, geophysical research, and space exploration.
The Foundation for Positive Mental Health
Grant in 2019
The Foundation for Positive Mental Health is a charity engaged in promoting skill training for positive mental health. They promote skills training for positive mental health to enhance everyday wellbeing and increase resilience to and recovery from mental health difficulties.
Empathy Lab
Grant in 2019
Empathy Lab operates as a dual-faceted organization, focusing on both digital strategy and the promotion of empathy through literature. In the digital realm, it provides comprehensive services to Fortune 500 companies and fast-growth organizations, specializing in broadband video, e-commerce, and community-driven experiences. Notable clients include major players in media, entertainment, and e-commerce, such as Sony and NBC Universal. In addition to its digital offerings, Empathy Lab is pioneering a unique approach to fostering children's empathy, literacy, and social activism through high-quality literature. This initiative is grounded in scientific research that highlights the role of reading in developing empathy skills among young readers.
Khulisa
Grant in 2019
Khulisa is an award-winning charity that recognises and addresses the social and emotional needs of the most vulnerable young people in the UK.
Franklin Scholars
Grant in 2019
Franklin Scholars is a social enterprise that operates an in-school literacy and numeracy peer mentoring program designed to support students transitioning from primary to secondary school. By training select students to tutor their younger peers, the program not only enhances the academic skills of the younger students but also fosters the tutors' own learning. The organization reinvests the majority of its profits to ensure sustainability and expand its impact, fulfilling its mission to improve educational outcomes for students during a critical phase of their academic journey.
Football Beyond Borders (FBB)
Grant in 2019
Football Beyond Borders is a youth organisation that uses young people's passion for football to educate and inspire them to be the best they can be.
Voice 21
Grant in 2019
Voice 21 is a charity dedicated to promoting the value of oracy in education in the schools that need it most. We provide professional and leadership development, school improvement and curriculum resources for teachers and schools.
Mind Moose
Grant in 2019
Mind Moose is an online platform designed to support children's mental well-being and provide early intervention for mental health issues. Founded in 2016 and headquartered in Alderley Edge, Cheshire, United Kingdom, the platform integrates psychological research with animated character education to foster self-awareness and self-esteem among children. By focusing on enhancing social, mental, and emotional health, Mind Moose aims to equip children with essential skills such as resilience, problem-solving, and emotional control.
MacMillan Academy
Grant in 2019
MacMillan Academy is an educational facility created to offer classrooms and learning settings for the instruction of students under the guidance of teachers. They support education's transformative potential and work to equip young people with the knowledge, resourcefulness, and creativity they need to face difficulties in the future. They encourage kids to acquire crucial abilities and receive consistent instruction in order to better prepare them for life beyond school.
Children's University (CU Trust)
Grant in 2019
Children's University is an award winning, critically acclaimed, extra-curricular and informal learning programme which takes education outside the normal school day and environment.Children's University encourage 5-14 year olds to challenge themselves, to try new experiences, to develop new interests and acquire new skills. Delivered at a local level by local partners, Children’s University operates across the British Isles with 125 centres as well as internationally in at least 4 countries with a further 10 expressions of interest.
Sidmouth College
Grant in 2019
Sidmouth College is a non-selective secondary school that provides a high standard of education. Their children succeed academically, expand their creative abilities, flourish in athletics, and experience a lot of new things in a welcoming environment.
Swoop
Grant in 2018
Swoop is a business funding and savings platform that helps companies find suitable financial solutions, including loans, equity, and grants. Utilizing an advanced matching algorithm, Swoop quickly assesses business needs and connects them with over a thousand providers in its network. In addition to facilitating access to funding, Swoop also identifies potential savings opportunities by analyzing expenditures in areas such as foreign exchange, utilities, broadband, and mobile services. This approach enables businesses to streamline their financial processes and secure the necessary resources for growth efficiently.
Px HealthCare
Grant in 2018
Px HealthCare focuses on enhancing patient outcomes in oncology through its innovative platform, OWise. This platform offers evidence-based mobile and web applications specifically designed for individuals diagnosed with breast or prostate cancer. OWise supports patients by providing personalized digital tools that facilitate real-time health data sharing with care teams and help bridge the evidence gap through patient-centric insights. As cancer care costs surpass $1.16 trillion annually, Px HealthCare aims to alleviate both individual and financial burdens by improving patient well-being and clinical results while reducing healthcare expenses. The OWise breast cancer app has received independent validation, garnering recommendations from 90% of patients and clinicians. Recognized for its excellence, OWise was selected by the NHS Innovation Accelerator and has received numerous awards. Additionally, Px HealthCare leverages advanced data analytics on anonymized patient-reported outcome data to offer valuable insights that contribute to better cancer treatment effectiveness and cost-efficiency on a global scale.
Citymart
Seed Round in 2018
Citymart is a provider of community development services aimed at enhancing city services and outcomes for residents. The company operates an online platform that facilitates collaboration among cities, enabling them to effectively identify needs, conduct market research, and connect with innovative vendors. By adopting best practices developed with leading cities globally, Citymart empowers over 100 cities across 35 countries to improve service delivery and address complex urban challenges. Through its tools and methods, Citymart seeks to transform how cities approach procurement and service improvement, ultimately benefiting both city workers and residents.
Featurespace
Venture Round in 2017
Featurespace is a leader in enterprise financial crime prevention, specializing in fraud detection and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are incorporated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries to identify fraudulent activities and suspicious behavior promptly. The ARIC Risk Hub utilizes advanced anomaly detection methods, allowing financial institutions to automatically recognize potential threats and respond to them effectively. Over 30 major global financial institutions, including well-known names such as HSBC and NatWest, leverage Featurespace’s solutions to safeguard their operations and enhance customer satisfaction while minimizing fraud-related costs.
Radio Physics Solutions
Series A in 2017
Radio Physics Solutions is a security and investigation company that specializes in the fields of real-time concealed threat detection, Up to 30m Distance, autonomous, and unobtrusive. It specializes in providing early warning of threats concealed under peoples’ clothes, and so reduce the number of casualties caused by terrorists and criminals globally at schools, train stations, airports, government and military installations, tourist attractions and entertainment venues. Radio Physics Solutions was founded in 2009 and headquartered in Cambridgeshire, United Kingdom.
CellCentric
Venture Round in 2017
CellCentric Ltd. is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative cancer therapeutic products. Established in 2003, the company specializes in small-molecule inhibitors that target p300 and CBP proteins, as well as a deubiquitinase enzyme closely linked to prostate cancer. This enzyme modulates the androgen receptor pathway, which is critical in addressing resistance mechanisms encountered with existing prostate cancer treatments. CellCentric's therapies aim to treat various cancers, including castrate-resistant prostate cancer, lung cancer, bladder cancer, non-small cell lung cancer, breast cancer, and colon cancer. By targeting specific pathways and mechanisms, CellCentric seeks to provide effective treatment options for patients with challenging cancer types.
Veryan Medical
Venture Round in 2017
Veryan Medical Ltd. specializes in the design and development of innovative vascular biomimetic stent technology. Founded in 2003 as a spin-out from Imperial College London, the company has created the BioMimics 3D stent, which utilizes a unique three-dimensional helical geometry to mimic natural blood vessel structure. This design enhances blood flow mechanics, promoting secondary swirling flow and increasing wall shear stress, which protects the endothelium and improves patient outcomes in treating symptomatic peripheral arterial disease. Veryan Medical is headquartered in Horsham, United Kingdom, with a research and development facility located in Galway, Ireland. The company operates as a subsidiary of Otsuka Medical Devices Co., Ltd. as of December 2018.
Lein Applied Diagnostics
Venture Round in 2017
Lein Applied Diagnostics Ltd. is a company focused on developing innovative measurement devices and solutions for the healthcare and industrial sectors. Founded in 2003 and based in Reading, United Kingdom, Lein specializes in optical metrology and non-invasive measurement technology. Its product lineup includes the Dione source/detector module for multi-layer thickness measurements, the compact Icon system for optical measurement of various materials, the fScan non-contact 3D fluorescence tracking plate reader for real-time measurements, and the CTS2 system for measuring the thickness of 3D engineered tissues and cells. These products cater to applications in metrology, pharmacokinetics, and diabetes care. Lein sells its solutions through agents in China, Japan, and North America, leveraging a strong suite of patents and a highly qualified engineering team to address complex measurement challenges in both organic and man-made materials.
Dialog Devices
Venture Round in 2017
Dialog Devices develops optical technologies to help meet the overwhelming demand for better healthcare. Its advanced opto-electronic technology is revolutionizing the way medical conditions are diagnosed and monitored; improving the health and well-being of people around the world. The company is also advancing additional applications for this technology including post-operative monitoring of peripheral interventions and diabetic neuropathy assessment.
Agilent Raman Spectroscopy
Venture Round in 2017
Agilent Raman Spectroscopy’s proprietary technologies use novel variants of Raman spectroscopy. Their instruments can rapidly and accurately identify materials hidden inside objects or through opaque barriers such as plastic, coloured glass, paper and skin, or can measure the concentrations of materials in mixtures, with a high degree of accuracy. Agilent Raman Spectroscopy is formerly known as Cobalt Light Systems and is part of Agilent.
Ashe Morris
Venture Round in 2017
Ashe Morris is developing a heat transfer technology that helps improve the efficiency of industrial processes and reduce energy consumption.
Cytox
Series B in 2017
Cytox Limited specializes in developing products and services aimed at diagnosing and treating neurodegenerative disorders, particularly Alzheimer's disease. The company has created a genetic-based blood test that assesses the risk and diagnosis of Alzheimer's in its early stages, addressing a critical need as the prevalence of the disease rises globally. Cytox's offerings include cellular and genetic assays for identifying cell cycle deficits in patients, along with biomarker and drug-screening services for pharmaceutical companies engaged in clinical trials. The company collaborates with Affymetrix, part of Thermo Fisher Scientific, to enhance its commercial testing capabilities. Founded in 2004 and headquartered in Birmingham, United Kingdom, with additional offices in Manchester and Oxford, Cytox serves pharmaceutical and biotechnology firms, as well as research laboratories involved in clinical research and drug development.
Probe Scientific
Venture Round in 2017
Probe Scientific Ltd. is a private company based in Coventry, United Kingdom, specializing in the development of medical devices and diagnostic products aimed at improving healthcare. Founded in 1998, the company has established a significant product pipeline featuring innovative technologies designed to address clinical challenges. Key products include MicroEye, which enables continuous online blood sampling, ContinuMon, an external monitoring system for lactate and glucose levels, and NanoEye, a monitoring device intended for use in neonatal and pediatric intensive care units. Probe Scientific's automated blood sampling technology supports a variety of applications, including critical care, therapeutic drug monitoring, and clinical research, reinforcing its commitment to enhancing patient care and advancing medical practices.
Orthogem
Venture Round in 2017
Orthogem Limited specializes in developing and manufacturing synthetic bone grafts, utilizing its patented Tripore technology platform. This innovative platform has led to a diverse range of synthetic bone grafts (SBGs) designed for various clinical applications, including spinal and oral craniofacial surgeries. Orthogem's product offerings include TriPore Granules, TriPore MPA, and TriPore Blocks. Established in 2001 and headquartered in Nottingham, United Kingdom, the company focuses on achieving optimal bone remodeling through the osteoconductive and bioactive properties of its materials. These grafts are applicable for treating a wide array of conditions, including fractures, congenital disorders, traumatic injuries, and bone cancer, thereby providing reliable solutions for patients undergoing procedures such as lumbar spine fusion.
BaseKit
Venture Round in 2017
BaseKit is a leading provider of website building and editing software, enabling individuals and businesses to establish a successful online presence. The company's solutions are widely deployed by hosting, telecommunications, and internet service providers, enhancing their offerings and improving customer satisfaction. BaseKit's software features seamless integration with existing products, account management, and billing systems, which helps clients grow their brands effectively. The platform supports various configurations, including on-premise installations, Software as a Service (SaaS), cPanel plugins, and Parallels APS. Additionally, BaseKit's application and documentation are available in 16 languages, catering to a diverse global audience.
Plaxica
Venture Round in 2017
Plaxica Limited is a technology and licensing company that specializes in the production of biopolymers and platform chemicals derived from renewable resources. Founded in 2008 and based in the United Kingdom, Plaxica develops innovative products such as Optipure® D Lactic Acid, Xylex® Lignin Free Sugars, and Versalac® Low Cost Lactic Acid technology. Its biopolymers, including polylactic acid, are utilized across various industries, including food packaging, automotive, textiles, electronics, and household goods. By focusing on sustainable materials, Plaxica aims to contribute to environmentally friendly solutions in multiple sectors.
PlayMob
Venture Round in 2017
PlayMob is a platform designed to connect brands and non-profit organizations with mobile gamers through purpose-driven content. By creating engaging mini-games, PlayMob enables brands to foster meaningful interactions with their audiences while addressing social issues. The platform emphasizes the importance of combining entertainment with charitable initiatives, allowing gamers to participate in solving problems and making a positive impact. This approach not only enhances the gaming experience but also helps brands improve their commercial outcomes by aligning their values with those of socially conscious consumers.
Smart Surgical Appliances
Venture Round in 2017
Smart Surgical Appliances is a medical device company focused on developing sensor-enabled surgical instruments that enhance the safety and effectiveness of minimally invasive procedures, including keyhole surgery, endoscopic surgery, and natural orifice transluminal endoscopic surgeries. The company's innovative instruments provide real-time sensing and feedback from the operative site, similar to the tactile feedback experienced in traditional surgeries. By improving the clinical efficacy of these procedures, Smart Surgical Appliances aims to reduce costs and minimize risks associated with surgical interventions, ultimately enhancing patient outcomes and the overall surgical experience for both physicians and patients.
designLED
Venture Round in 2017
Design LED Products Ltd. specializes in the design and manufacturing of innovative lighting solutions, including LED lighting tiles and various backlighting products. The company uses advanced optical resins and films to create a range of products, such as shelf luminaires for product illumination and signage that features both convex and concave designs. Operating under several brands, including Edinburgh and Ness, Design LED serves multiple sectors, including architectural, retail, and automotive applications. Since its incorporation in 2003, the company has focused on delivering energy-efficient, differentiated lighting options to meet the growing global demand for sustainable lighting solutions. With a commitment to transforming the approach to lighting products, Design LED Products aims to be a leader in the rapidly expanding international lighting market.
Camfridge
Venture Round in 2017
Camfridge Ltd, based in Cambridge, United Kingdom, specializes in the development of low carbon cooling products for appliance manufacturers. Established in 2003, the company employs innovative magnetic cooling technology that utilizes metal alloys and magnetic fields to create an energy-efficient cooling cycle. This approach significantly reduces energy consumption and eliminates the need for polluting gases, making it an environmentally friendly alternative for both domestic and commercial appliances. Camfridge's advancements in gas-free magnetic cooling have earned recognition, including a spot in the Cleantech 100, highlighting its position among the top private clean technology companies in Europe.
ProKyma
Venture Round in 2017
ProKyma specializes in advanced cell separation technology aimed at enhancing molecular biology tests. The company focuses on refining blood tests for Circulating Tumour Cells (CTCs), which play a crucial role in the early detection of cancer metastasis and in monitoring treatment responses. Originating as a spinout from Dstl Porton Down, ProKyma leverages research into separation technologies to develop its solutions. Utilizing a combination of high frequency ultrasound and magnetism, the company effectively manipulates, concentrates, and purifies biological cells from complex samples. This innovative approach has broad applications across various sectors, including clinical, food, environmental, and pharmaceutical industries, thereby contributing to improved patient care and treatment monitoring.
eoSemi
Venture Round in 2017
eoSemi Ltd. is a semiconductor company based in Congleton, United Kingdom, founded in 2005. The company specializes in developing silicon-based oscillators, particularly CMOS oscillator technology, which integrates into systems on chips and microcontroller units. These oscillators provide precise frequency, clocking, and timing for wireline connected systems while also offering low power consumption. eoSemi addresses the challenges posed by shrinking electronic systems that require smaller yet high-performance timing devices. By leveraging advanced technology, eoSemi creates compact designs that enhance product capabilities and enable new applications, thus improving synchronization and connectivity within communications networks.
ATS
Venture Round in 2017
ATS
Symetrica
Venture Round in 2017
Symetrica Ltd. specializes in the development and commercialization of integrated radiation detection and identification technologies tailored for government and custom organizations across the globe. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, the company offers advanced systems that enhance security operations in various sectors, including military and homeland security. Its product range features handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, all utilizing machine learning to improve threat identification and response. Symetrica's technology is also applicable in fields such as medical diagnostics, geophysical research, and space exploration.
Surface Generation
Venture Round in 2017
Surface Generation Ltd. is a high technology and manufacturing company based in Oakham, United Kingdom, with additional facilities in North America and Asia. Founded in 2002, the company specializes in developing and commercializing composite processing equipment for the aerospace, automotive, and consumer electronics industries. Its patented Production to Functional Specification (PtFS) technology optimizes the use of composite materials, such as carbon fiber, enabling clients to produce high-performance products like aircraft wings, automotive components, and consumer devices. Surface Generation also provides manufacturing solutions for creating coupons, sub-element components, and demonstrator articles, as well as custom equipment for various applications, including oil and gas and academic research. The company's innovations help manufacturers save costs and energy while producing lighter weight products.
Six to Start
Venture Round in 2017
Six to Start Limited is an independent game developer based in London, specializing in alternate reality games that blend digital and physical experiences. Founded in 2007, the company leverages multiple media channels, including the web, mobile devices, and live events, to create immersive storytelling experiences. Six to Start is best known for its flagship product, Zombies, Run!, which has become the world's bestselling smartphone fitness app. The company also developed The Walk, the first smartphone fitness game funded by the UK's Department of Health. In addition to game development, Six to Start provides consulting services tailored to the entertainment and advertising industries, helping clients create engaging, interactive experiences that resonate with audiences in real time.
Kaptivo
Venture Round in 2017
Kaptivo is a developer of a whiteboard camera that enhances visual collaboration through artificial intelligence. Its product enables live-streamed whiteboard content during remote meetings, incorporating features such as automatic note-taking to facilitate communication and productivity. Kaptivo's technology is utilized by businesses and educational institutions, allowing them to seamlessly integrate with popular collaboration tools like Zoom, Cisco Webex, Microsoft Teams, and Slack. This integration supports secure content sharing, ultimately improving the efficiency of remote interactions.
Featurespace
Venture Round in 2016
Featurespace is a leader in enterprise financial crime prevention, specializing in fraud detection and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are incorporated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries to identify fraudulent activities and suspicious behavior promptly. The ARIC Risk Hub utilizes advanced anomaly detection methods, allowing financial institutions to automatically recognize potential threats and respond to them effectively. Over 30 major global financial institutions, including well-known names such as HSBC and NatWest, leverage Featurespace’s solutions to safeguard their operations and enhance customer satisfaction while minimizing fraud-related costs.
Featurespace
Funding Round in 2014
Featurespace is a leader in enterprise financial crime prevention, specializing in fraud detection and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are incorporated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries to identify fraudulent activities and suspicious behavior promptly. The ARIC Risk Hub utilizes advanced anomaly detection methods, allowing financial institutions to automatically recognize potential threats and respond to them effectively. Over 30 major global financial institutions, including well-known names such as HSBC and NatWest, leverage Featurespace’s solutions to safeguard their operations and enhance customer satisfaction while minimizing fraud-related costs.
The Behavioural Insights Team
Venture Round in 2014
The Behavioural Insights Team is an organization dedicated to applying nudge theory to enhance government policy and public services. Established as a joint venture between its employees, the UK government, and Nesta, a leading innovation charity, the team focuses on integrating insights from behavioral economics, psychology, and social anthropology. By understanding how individuals make decisions and respond to various options, the team aims to design effective policies and interventions that empower people to make better choices for themselves and society. Collaborating with governments, local authorities, businesses, and charities, the organization seeks to improve public outcomes and foster positive community impact through informed decision-making.
BaseKit
Venture Round in 2014
BaseKit is a leading provider of website building and editing software, enabling individuals and businesses to establish a successful online presence. The company's solutions are widely deployed by hosting, telecommunications, and internet service providers, enhancing their offerings and improving customer satisfaction. BaseKit's software features seamless integration with existing products, account management, and billing systems, which helps clients grow their brands effectively. The platform supports various configurations, including on-premise installations, Software as a Service (SaaS), cPanel plugins, and Parallels APS. Additionally, BaseKit's application and documentation are available in 16 languages, catering to a diverse global audience.
Haemostatix
Venture Round in 2012
Haemostatix Ltd., founded in 2003 and based in Nottingham, United Kingdom, specializes in developing a peptide-based platform technology aimed at addressing surgical bleeding and advancing tissue repair and regenerative medicine. The company originated as a spin-out from the University of Leicester and was co-founded by Sarah Middleton and Professor Alison Goodall. Its product pipeline includes PeproStat, a coagulant applied directly to wounds to effectively manage bleeding during surgical procedures. Haemostatix also focuses on creating various forms of hemostats, including liquid and transparent gel formulations, which enhance the speed and safety of bleeding control for healthcare professionals. As of May 2016, Haemostatix operates as a subsidiary of Ergomed plc.
Featurespace
Funding Round in 2012
Featurespace is a leader in enterprise financial crime prevention, specializing in fraud detection and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are incorporated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries to identify fraudulent activities and suspicious behavior promptly. The ARIC Risk Hub utilizes advanced anomaly detection methods, allowing financial institutions to automatically recognize potential threats and respond to them effectively. Over 30 major global financial institutions, including well-known names such as HSBC and NatWest, leverage Featurespace’s solutions to safeguard their operations and enhance customer satisfaction while minimizing fraud-related costs.
PlayMob
Venture Round in 2012
PlayMob is a platform designed to connect brands and non-profit organizations with mobile gamers through purpose-driven content. By creating engaging mini-games, PlayMob enables brands to foster meaningful interactions with their audiences while addressing social issues. The platform emphasizes the importance of combining entertainment with charitable initiatives, allowing gamers to participate in solving problems and making a positive impact. This approach not only enhances the gaming experience but also helps brands improve their commercial outcomes by aligning their values with those of socially conscious consumers.
Sirigen
Venture Round in 2012
Sirigen, Inc. is a biotechnology company based in La Jolla, California, specializing in High Sensitivity Fluorescence (HSF) detection technology for the diagnostic and life science markets. Founded in 2003, Sirigen develops innovative fluorescent polymers and conjugates that enhance stain index performance in flow cytometry. Their products are utilized in a variety of applications, including immunoassays, ELISA, biomarkers, proteomics, molecular diagnostics, and various forms of microscopy and blotting techniques. Sirigen's technology streamlines sample processing and instrumentation requirements, enabling efficient high-volume screening in diagnostics and personal care applications. The company operates as a subsidiary of Becton, Dickinson and Company.
Skimlinks
Series B in 2011
Skimlinks is a prominent commerce content monetization platform that enables publishers to generate new revenue streams, reducing their reliance on traditional advertising. The platform automatically generates income for publishers by monetizing product links within commerce-related content, earning them a share of sales when readers make purchases through these links. Skimlinks provides access to over 60 affiliate networks, allowing publishers to earn commissions from approximately 27,000 merchants globally. The technology is designed to enhance click-through rates and earnings per click, thereby maximizing revenue potential. In 2017, the annual e-commerce transactions facilitated through Skimlinks' network reached $1 billion. The company serves a diverse clientele, including many of the top publishers in the US and UK, such as Conde Nast, Hearst, Buzzfeed, and the Huffington Post.
Sirigen
Venture Round in 2011
Sirigen, Inc. is a biotechnology company based in La Jolla, California, specializing in High Sensitivity Fluorescence (HSF) detection technology for the diagnostic and life science markets. Founded in 2003, Sirigen develops innovative fluorescent polymers and conjugates that enhance stain index performance in flow cytometry. Their products are utilized in a variety of applications, including immunoassays, ELISA, biomarkers, proteomics, molecular diagnostics, and various forms of microscopy and blotting techniques. Sirigen's technology streamlines sample processing and instrumentation requirements, enabling efficient high-volume screening in diagnostics and personal care applications. The company operates as a subsidiary of Becton, Dickinson and Company.
Haemostatix
Series C in 2011
Haemostatix Ltd., founded in 2003 and based in Nottingham, United Kingdom, specializes in developing a peptide-based platform technology aimed at addressing surgical bleeding and advancing tissue repair and regenerative medicine. The company originated as a spin-out from the University of Leicester and was co-founded by Sarah Middleton and Professor Alison Goodall. Its product pipeline includes PeproStat, a coagulant applied directly to wounds to effectively manage bleeding during surgical procedures. Haemostatix also focuses on creating various forms of hemostats, including liquid and transparent gel formulations, which enhance the speed and safety of bleeding control for healthcare professionals. As of May 2016, Haemostatix operates as a subsidiary of Ergomed plc.
Cellnovo
Series B in 2011
CellNovo is a medical device company focused on diabetes management. The company develops and markets a comprehensive system that includes a cordless micro-pump, an integrated monitoring device, and a cellular handset with a touch screen and embedded blood glucose meter. This innovative system facilitates the automatic transmission of data, allowing for real-time monitoring of patients' conditions through mobile connectivity. By creating an interconnected diabetes management solution, CellNovo aims to enhance the quality of care for individuals living with diabetes.
Haemostatix
Venture Round in 2010
Haemostatix Ltd., founded in 2003 and based in Nottingham, United Kingdom, specializes in developing a peptide-based platform technology aimed at addressing surgical bleeding and advancing tissue repair and regenerative medicine. The company originated as a spin-out from the University of Leicester and was co-founded by Sarah Middleton and Professor Alison Goodall. Its product pipeline includes PeproStat, a coagulant applied directly to wounds to effectively manage bleeding during surgical procedures. Haemostatix also focuses on creating various forms of hemostats, including liquid and transparent gel formulations, which enhance the speed and safety of bleeding control for healthcare professionals. As of May 2016, Haemostatix operates as a subsidiary of Ergomed plc.
Kaptivo
Series B in 2010
Kaptivo is a developer of a whiteboard camera that enhances visual collaboration through artificial intelligence. Its product enables live-streamed whiteboard content during remote meetings, incorporating features such as automatic note-taking to facilitate communication and productivity. Kaptivo's technology is utilized by businesses and educational institutions, allowing them to seamlessly integrate with popular collaboration tools like Zoom, Cisco Webex, Microsoft Teams, and Slack. This integration supports secure content sharing, ultimately improving the efficiency of remote interactions.
Sirigen
Venture Round in 2010
Sirigen, Inc. is a biotechnology company based in La Jolla, California, specializing in High Sensitivity Fluorescence (HSF) detection technology for the diagnostic and life science markets. Founded in 2003, Sirigen develops innovative fluorescent polymers and conjugates that enhance stain index performance in flow cytometry. Their products are utilized in a variety of applications, including immunoassays, ELISA, biomarkers, proteomics, molecular diagnostics, and various forms of microscopy and blotting techniques. Sirigen's technology streamlines sample processing and instrumentation requirements, enabling efficient high-volume screening in diagnostics and personal care applications. The company operates as a subsidiary of Becton, Dickinson and Company.
eoSemi
Venture Round in 2010
eoSemi Ltd. is a semiconductor company based in Congleton, United Kingdom, founded in 2005. The company specializes in developing silicon-based oscillators, particularly CMOS oscillator technology, which integrates into systems on chips and microcontroller units. These oscillators provide precise frequency, clocking, and timing for wireline connected systems while also offering low power consumption. eoSemi addresses the challenges posed by shrinking electronic systems that require smaller yet high-performance timing devices. By leveraging advanced technology, eoSemi creates compact designs that enhance product capabilities and enable new applications, thus improving synchronization and connectivity within communications networks.
BaseKit
Series A in 2010
BaseKit is a leading provider of website building and editing software, enabling individuals and businesses to establish a successful online presence. The company's solutions are widely deployed by hosting, telecommunications, and internet service providers, enhancing their offerings and improving customer satisfaction. BaseKit's software features seamless integration with existing products, account management, and billing systems, which helps clients grow their brands effectively. The platform supports various configurations, including on-premise installations, Software as a Service (SaaS), cPanel plugins, and Parallels APS. Additionally, BaseKit's application and documentation are available in 16 languages, catering to a diverse global audience.
Aquapharm Biodiscovery
Series C in 2010
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.
Veryan Medical
Series A in 2010
Veryan Medical Ltd. specializes in the design and development of innovative vascular biomimetic stent technology. Founded in 2003 as a spin-out from Imperial College London, the company has created the BioMimics 3D stent, which utilizes a unique three-dimensional helical geometry to mimic natural blood vessel structure. This design enhances blood flow mechanics, promoting secondary swirling flow and increasing wall shear stress, which protects the endothelium and improves patient outcomes in treating symptomatic peripheral arterial disease. Veryan Medical is headquartered in Horsham, United Kingdom, with a research and development facility located in Galway, Ireland. The company operates as a subsidiary of Otsuka Medical Devices Co., Ltd. as of December 2018.
Skimlinks
Series A in 2009
Skimlinks is a prominent commerce content monetization platform that enables publishers to generate new revenue streams, reducing their reliance on traditional advertising. The platform automatically generates income for publishers by monetizing product links within commerce-related content, earning them a share of sales when readers make purchases through these links. Skimlinks provides access to over 60 affiliate networks, allowing publishers to earn commissions from approximately 27,000 merchants globally. The technology is designed to enhance click-through rates and earnings per click, thereby maximizing revenue potential. In 2017, the annual e-commerce transactions facilitated through Skimlinks' network reached $1 billion. The company serves a diverse clientele, including many of the top publishers in the US and UK, such as Conde Nast, Hearst, Buzzfeed, and the Huffington Post.
Lein Applied Diagnostics
Seed Round in 2009
Lein Applied Diagnostics Ltd. is a company focused on developing innovative measurement devices and solutions for the healthcare and industrial sectors. Founded in 2003 and based in Reading, United Kingdom, Lein specializes in optical metrology and non-invasive measurement technology. Its product lineup includes the Dione source/detector module for multi-layer thickness measurements, the compact Icon system for optical measurement of various materials, the fScan non-contact 3D fluorescence tracking plate reader for real-time measurements, and the CTS2 system for measuring the thickness of 3D engineered tissues and cells. These products cater to applications in metrology, pharmacokinetics, and diabetes care. Lein sells its solutions through agents in China, Japan, and North America, leveraging a strong suite of patents and a highly qualified engineering team to address complex measurement challenges in both organic and man-made materials.
Plaxica
Venture Round in 2009
Plaxica Limited is a technology and licensing company that specializes in the production of biopolymers and platform chemicals derived from renewable resources. Founded in 2008 and based in the United Kingdom, Plaxica develops innovative products such as Optipure® D Lactic Acid, Xylex® Lignin Free Sugars, and Versalac® Low Cost Lactic Acid technology. Its biopolymers, including polylactic acid, are utilized across various industries, including food packaging, automotive, textiles, electronics, and household goods. By focusing on sustainable materials, Plaxica aims to contribute to environmentally friendly solutions in multiple sectors.
BaseKit
Venture Round in 2009
BaseKit is a leading provider of website building and editing software, enabling individuals and businesses to establish a successful online presence. The company's solutions are widely deployed by hosting, telecommunications, and internet service providers, enhancing their offerings and improving customer satisfaction. BaseKit's software features seamless integration with existing products, account management, and billing systems, which helps clients grow their brands effectively. The platform supports various configurations, including on-premise installations, Software as a Service (SaaS), cPanel plugins, and Parallels APS. Additionally, BaseKit's application and documentation are available in 16 languages, catering to a diverse global audience.
Kaptivo
Series A in 2009
Kaptivo is a developer of a whiteboard camera that enhances visual collaboration through artificial intelligence. Its product enables live-streamed whiteboard content during remote meetings, incorporating features such as automatic note-taking to facilitate communication and productivity. Kaptivo's technology is utilized by businesses and educational institutions, allowing them to seamlessly integrate with popular collaboration tools like Zoom, Cisco Webex, Microsoft Teams, and Slack. This integration supports secure content sharing, ultimately improving the efficiency of remote interactions.
Smart Surgical Appliances
Seed Round in 2009
Smart Surgical Appliances is a medical device company focused on developing sensor-enabled surgical instruments that enhance the safety and effectiveness of minimally invasive procedures, including keyhole surgery, endoscopic surgery, and natural orifice transluminal endoscopic surgeries. The company's innovative instruments provide real-time sensing and feedback from the operative site, similar to the tactile feedback experienced in traditional surgeries. By improving the clinical efficacy of these procedures, Smart Surgical Appliances aims to reduce costs and minimize risks associated with surgical interventions, ultimately enhancing patient outcomes and the overall surgical experience for both physicians and patients.
Skimlinks
Seed Round in 2009
Skimlinks is a prominent commerce content monetization platform that enables publishers to generate new revenue streams, reducing their reliance on traditional advertising. The platform automatically generates income for publishers by monetizing product links within commerce-related content, earning them a share of sales when readers make purchases through these links. Skimlinks provides access to over 60 affiliate networks, allowing publishers to earn commissions from approximately 27,000 merchants globally. The technology is designed to enhance click-through rates and earnings per click, thereby maximizing revenue potential. In 2017, the annual e-commerce transactions facilitated through Skimlinks' network reached $1 billion. The company serves a diverse clientele, including many of the top publishers in the US and UK, such as Conde Nast, Hearst, Buzzfeed, and the Huffington Post.
Camrivox
Venture Round in 2009
Camrivox Ltd, founded in 2005 and headquartered in Cambridge, UK, specializes in providing telephony integration solutions for customer relationship management (CRM). The company has developed Flexor Software, which simplifies the integration of telephony with CRM systems, eliminating the need for significant investments in infrastructure and support staff. By delivering this software directly at the PC level, Camrivox enables businesses to enhance their communication processes, streamline operations, and improve customer satisfaction. Additionally, the company manufactures voice-over internet protocol (VoIP) equipment targeted at home users and small businesses, facilitating the integration of telephony, instant messaging, and presence management within CRM services.
Skimlinks
Venture Round in 2009
Skimlinks is a prominent commerce content monetization platform that enables publishers to generate new revenue streams, reducing their reliance on traditional advertising. The platform automatically generates income for publishers by monetizing product links within commerce-related content, earning them a share of sales when readers make purchases through these links. Skimlinks provides access to over 60 affiliate networks, allowing publishers to earn commissions from approximately 27,000 merchants globally. The technology is designed to enhance click-through rates and earnings per click, thereby maximizing revenue potential. In 2017, the annual e-commerce transactions facilitated through Skimlinks' network reached $1 billion. The company serves a diverse clientele, including many of the top publishers in the US and UK, such as Conde Nast, Hearst, Buzzfeed, and the Huffington Post.
Dexela
Venture Round in 2009
Dexela develops advanced 3-D breast imaging technology aimed at the early detection of breast cancer. The company offers a range of products, including the DexTop Digital Mammography Workstation, which streamlines screening workflow and performance, and a 3D reconstruction engine available to OEM partners as a software module. Dexela's flat panel CMOS X-ray detectors serve various medical applications, such as mammography, breast CT, dental imaging, and fluoroscopy. Additionally, the company provides consulting services in digital tomosynthesis, mammography acquisition geometry, and the optimal reconstruction of 3D data. Founded in 2003 and headquartered in London, Dexela also operates an X-ray research and development facility in Sudbury, Massachusetts.
MMIC Solutions
Series A in 2008
MMIC Solutions is deploying technology to allow the commercial use of high frequencies in the millimeter wave bands. The company develops, manufactures, and supplys innovative solutions for a range of systems operating at frequencies between 50GHz and 250GHz
Haemostatix
Venture Round in 2008
Haemostatix Ltd., founded in 2003 and based in Nottingham, United Kingdom, specializes in developing a peptide-based platform technology aimed at addressing surgical bleeding and advancing tissue repair and regenerative medicine. The company originated as a spin-out from the University of Leicester and was co-founded by Sarah Middleton and Professor Alison Goodall. Its product pipeline includes PeproStat, a coagulant applied directly to wounds to effectively manage bleeding during surgical procedures. Haemostatix also focuses on creating various forms of hemostats, including liquid and transparent gel formulations, which enhance the speed and safety of bleeding control for healthcare professionals. As of May 2016, Haemostatix operates as a subsidiary of Ergomed plc.
Micrima
Venture Round in 2008
Micrima Limited is a company based in Bristol, United Kingdom, specializing in the development and commercialization of advanced imaging technology for early breast cancer detection. The firm has created an ergonomic imaging system branded as MARIA, which employs microwave radar technology to provide non-ionizing imaging services. This system features a horizontal couch and a hemispherical scanning head designed to accommodate various breast sizes without the need for breast compression, offering a more comfortable experience for patients. Micrima is also focused on developing algorithms for processing the data collected during imaging. Initially spun out from research at the University of Bristol, the company has conducted extensive laboratory validation of its technology and is currently conducting human use trials. Micrima primarily serves breast cancer imaging centers and healthcare providers across the UK, aiming to provide a painless and efficient alternative for routine breast cancer screening.
Gnodal
Seed Round in 2008
Gnodal, founded in 2007 by a team of IT infrastructure design experts, specializes in developing advanced technology aimed at enhancing performance and efficiency in data centers. The company focuses on creating systems that significantly reduce power consumption and operational costs while also providing high scalability for growing demands. Through a combination of design, manufacture, and deployment expertise, Gnodal is committed to revolutionizing the data center landscape with its innovative solutions, positioning itself as a leader in the high-performance data center market.
ProVision Communications
Seed Round in 2008
ProVision Communications specializes in digital wireless technology, focusing on the design, development, and licensing of innovative solutions for high-definition television distribution. Founded by two esteemed university professors with expertise in wireless and video technologies, ProVision leverages their knowledge to create products that ensure reliable HD video display, even in challenging environments affected by movement and structural variations in homes. The company's primary technology platforms include AXAR, which facilitates all-room wireless distribution of HDTV, and ProMultiVu, designed for multi-cast video transmission at outdoor events. ProMultiVu is particularly versatile, enabling video reception on devices such as laptops, PDAs, and smartphones. ProVision serves a diverse clientele, including consumer electronics manufacturers and multinational original equipment manufacturers.
Cellnovo
Series A in 2008
CellNovo is a medical device company focused on diabetes management. The company develops and markets a comprehensive system that includes a cordless micro-pump, an integrated monitoring device, and a cellular handset with a touch screen and embedded blood glucose meter. This innovative system facilitates the automatic transmission of data, allowing for real-time monitoring of patients' conditions through mobile connectivity. By creating an interconnected diabetes management solution, CellNovo aims to enhance the quality of care for individuals living with diabetes.
CellCentric
Venture Round in 2007
CellCentric Ltd. is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative cancer therapeutic products. Established in 2003, the company specializes in small-molecule inhibitors that target p300 and CBP proteins, as well as a deubiquitinase enzyme closely linked to prostate cancer. This enzyme modulates the androgen receptor pathway, which is critical in addressing resistance mechanisms encountered with existing prostate cancer treatments. CellCentric's therapies aim to treat various cancers, including castrate-resistant prostate cancer, lung cancer, bladder cancer, non-small cell lung cancer, breast cancer, and colon cancer. By targeting specific pathways and mechanisms, CellCentric seeks to provide effective treatment options for patients with challenging cancer types.
Kaptivo
Series A in 2007
Kaptivo is a developer of a whiteboard camera that enhances visual collaboration through artificial intelligence. Its product enables live-streamed whiteboard content during remote meetings, incorporating features such as automatic note-taking to facilitate communication and productivity. Kaptivo's technology is utilized by businesses and educational institutions, allowing them to seamlessly integrate with popular collaboration tools like Zoom, Cisco Webex, Microsoft Teams, and Slack. This integration supports secure content sharing, ultimately improving the efficiency of remote interactions.
Aquapharm Biodiscovery
Series B in 2007
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.
Veryan Medical
Venture Round in 2007
Veryan Medical Ltd. specializes in the design and development of innovative vascular biomimetic stent technology. Founded in 2003 as a spin-out from Imperial College London, the company has created the BioMimics 3D stent, which utilizes a unique three-dimensional helical geometry to mimic natural blood vessel structure. This design enhances blood flow mechanics, promoting secondary swirling flow and increasing wall shear stress, which protects the endothelium and improves patient outcomes in treating symptomatic peripheral arterial disease. Veryan Medical is headquartered in Horsham, United Kingdom, with a research and development facility located in Galway, Ireland. The company operates as a subsidiary of Otsuka Medical Devices Co., Ltd. as of December 2018.
Symetrica
Series C in 2007
Symetrica Ltd. specializes in the development and commercialization of integrated radiation detection and identification technologies tailored for government and custom organizations across the globe. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, the company offers advanced systems that enhance security operations in various sectors, including military and homeland security. Its product range features handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, all utilizing machine learning to improve threat identification and response. Symetrica's technology is also applicable in fields such as medical diagnostics, geophysical research, and space exploration.
MMIC Solutions
Seed Round in 2006
MMIC Solutions is deploying technology to allow the commercial use of high frequencies in the millimeter wave bands. The company develops, manufactures, and supplys innovative solutions for a range of systems operating at frequencies between 50GHz and 250GHz
Kaptivo
Venture Round in 2006
Kaptivo is a developer of a whiteboard camera that enhances visual collaboration through artificial intelligence. Its product enables live-streamed whiteboard content during remote meetings, incorporating features such as automatic note-taking to facilitate communication and productivity. Kaptivo's technology is utilized by businesses and educational institutions, allowing them to seamlessly integrate with popular collaboration tools like Zoom, Cisco Webex, Microsoft Teams, and Slack. This integration supports secure content sharing, ultimately improving the efficiency of remote interactions.
CellCentric
Venture Round in 2006
CellCentric Ltd. is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative cancer therapeutic products. Established in 2003, the company specializes in small-molecule inhibitors that target p300 and CBP proteins, as well as a deubiquitinase enzyme closely linked to prostate cancer. This enzyme modulates the androgen receptor pathway, which is critical in addressing resistance mechanisms encountered with existing prostate cancer treatments. CellCentric's therapies aim to treat various cancers, including castrate-resistant prostate cancer, lung cancer, bladder cancer, non-small cell lung cancer, breast cancer, and colon cancer. By targeting specific pathways and mechanisms, CellCentric seeks to provide effective treatment options for patients with challenging cancer types.
Meciria
Venture Round in 2006
Meciria develops an oil well drilling tool for the oil industry.
Micrima
Venture Round in 2006
Micrima Limited is a company based in Bristol, United Kingdom, specializing in the development and commercialization of advanced imaging technology for early breast cancer detection. The firm has created an ergonomic imaging system branded as MARIA, which employs microwave radar technology to provide non-ionizing imaging services. This system features a horizontal couch and a hemispherical scanning head designed to accommodate various breast sizes without the need for breast compression, offering a more comfortable experience for patients. Micrima is also focused on developing algorithms for processing the data collected during imaging. Initially spun out from research at the University of Bristol, the company has conducted extensive laboratory validation of its technology and is currently conducting human use trials. Micrima primarily serves breast cancer imaging centers and healthcare providers across the UK, aiming to provide a painless and efficient alternative for routine breast cancer screening.
Veryan Medical
Series A in 2005
Veryan Medical Ltd. specializes in the design and development of innovative vascular biomimetic stent technology. Founded in 2003 as a spin-out from Imperial College London, the company has created the BioMimics 3D stent, which utilizes a unique three-dimensional helical geometry to mimic natural blood vessel structure. This design enhances blood flow mechanics, promoting secondary swirling flow and increasing wall shear stress, which protects the endothelium and improves patient outcomes in treating symptomatic peripheral arterial disease. Veryan Medical is headquartered in Horsham, United Kingdom, with a research and development facility located in Galway, Ireland. The company operates as a subsidiary of Otsuka Medical Devices Co., Ltd. as of December 2018.
Symetrica
Series B in 2005
Symetrica Ltd. specializes in the development and commercialization of integrated radiation detection and identification technologies tailored for government and custom organizations across the globe. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, the company offers advanced systems that enhance security operations in various sectors, including military and homeland security. Its product range features handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, all utilizing machine learning to improve threat identification and response. Symetrica's technology is also applicable in fields such as medical diagnostics, geophysical research, and space exploration.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.